Stay updated on Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.

Latest updates to the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page
- Check5 days agoChange DetectedA new 2026-09-04 history entry including a Study Status line and the value 447 was added. The 2026-08-04 entry was deleted.SummaryDifference0.0%

- Check12 days agoChange DetectedA new revision tag v3.6.6 is listed in the history, replacing the prior v3.6.5; this reflects a metadata update to the page rather than substantive changes to study data.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe record history now shows the latest revision label as v3.6.5, replacing the previous v3.6.4. This reflects a metadata update to the study history rather than substantive content changes.SummaryDifference0.0%

- Check40 days agoChange DetectedNew history entries appear for 2026-08-01 and 2026-08-04 updating the Study Status and Contacts/Locations (versions 445 and 446). The 2026-07-02 entry is removed.SummaryDifference0.1%

- Check47 days agoChange DetectedA new revision label v3.6.4 appears in the history, replacing the previous v3.6.3. This indicates the page was updated to a newer build.SummaryDifference0.0%

- Check68 days agoChange DetectedA new version entry dated 2026-07-02 was added to the record history, updating the Study Status and Contacts/Locations sections (with an associated 2026-07-01 entry and a 444 marker). The 2026-06-15 entry was deleted.SummaryDifference0.1%

Stay in the know with updates to Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.